Stay updated on ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Sign up to get notified when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.

Latest updates to the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page
- CheckyesterdayChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2. Removed the older PubMed sourcing note and revision v3.2.0.SummaryDifference0.1%

- Check8 days agoChange DetectedRemoved the generic government funding/operating status notice from the page; the study details and other content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNo significant changes detected in core study details or design. The page information remains consistent with the prior version.SummaryDifference0.4%

- Check51 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%

- Check58 days agoChange DetectedAdds version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) plus an older version tag (v3.0.2).SummaryDifference0.3%

- Check72 days agoChange DetectedUpdated to v3.0.2; 'Back to Top' removed. No changes to core content or critical data.SummaryDifference0.2%

Stay in the know with updates to ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.